Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma

被引:11
作者
Park, Kil Hyo [1 ]
Kwon, Soon Ha [1 ]
Lee, Yong Sub [1 ]
Jeong, Soung Won [1 ]
Jang, Jae Young [1 ]
Lee, Sae Hwan [1 ]
Kim, Sang Gyune [1 ]
Cha, Sang-Woo [1 ]
Kim, Young Seok [1 ]
Cho, Young Deok [1 ]
Kim, Hong Soo [1 ]
Kim, Boo Sung [1 ]
Kim, Yong Jae [2 ]
机构
[1] Soonchunhyang Univ Hosp, Digest Dis Ctr, Inst Digest Res, Dept Internal Med, Seoul, South Korea
[2] Soonchunhyang Univ Hosp, Digest Dis Ctr, Inst Digest Res, Dept Radiol, Seoul, South Korea
关键词
Transarterial chemoembolization; Contrast; enhanced ultrasonography; Hepatocellular carcinoma; Tumor size; Feeding artery;
D O I
10.3350/cmh.2015.21.2.158
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: The predictive role of contrast-enhanced ultrasonography (CEUS) before performing transarterial chemoembolization (TACE) has not been determined. We assessed the possible predictive factors of CEUS for the response to TACE. Methods: Seventeen patients with 18 hepatocellular carcinoma (HCC) underwent TACE. All of the tumors were studied with CEUS before TACE using a second-generation ultrasound contrast agent (SonoVue (R), Bracco, Milan, Italy). The tumor response to TACE was classified with a score between 1 and 4 according to the remaining enhancing-tumor percentage based on modified response evaluation criteria in solid tumors (mRECIST): 1, enhancing tumor <25%; 2, 25%<= enhancing tumor<50%; 3, 50%<= enhancing tumor<75%; and 4, enhancing tumor >= 75%). A score of 1 was defined as a "good response" to TACE. The predictive factors for the response to TACE were evaluated during CEUS based on the maximum tumor diameter, initial arterial enhancing time, arterial enhancing duration, intensity of arterial enhancement, presence of a hypoenhanced pattern, and the feeding artery to the tumor. Results: The median tumor size was 3.1 cm. The distribution of tumor response scores after TACE in all tumors was as follows: 1, n=11; 2, n=4; 3, n=2; and 4, n=1. Fifteen tumors showed feeding arteries. The presence of a feeding artery and the tumor size (<= 5 cm) were the predictive factors for a good response (P=0.043 and P=0.047, respectively). Conclusions: The presence of a feeding artery and a tumor size of less than 5 cm were the predictive factors for a good response of HCC to TACE on CEUS.
引用
收藏
页码:158 / 164
页数:7
相关论文
共 50 条
[41]   Unenhanced and Contrast-Enhanced Ultrasonography During Hepatic Transarterial Embolization and Chemoembolization With Drug-Eluting Beads [J].
Hippocrates Moschouris ;
Katerina Malagari ;
Ioannis Kornezos ;
Marina Georgiou Papadaki ;
Panagiotis Gkoutzios ;
Dimitrios Matsaidonis .
CardioVascular and Interventional Radiology, 2010, 33 :1215-1222
[42]   TUMOR VASCULAR NETWORKS DEPICTED IN CONTRAST-ENHANCED ULTRASOUND IMAGES AS A PREDICTOR FOR TRANSARTERIAL CHEMOEMBOLIZATION TREATMENT RESPONSE [J].
Oezdemir, Ipek ;
Wessner, Corrine E. ;
Shaw, Colette ;
Eisenbrey, John R. ;
Hoyt, Kenneth .
ULTRASOUND IN MEDICINE AND BIOLOGY, 2020, 46 (09) :2276-2286
[43]   Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: A pilot study [J].
Shiozawa, Kazue ;
Watanabe, Manabu ;
Kikuchi, Yoshinori ;
Kudo, Takahide ;
Maruyama, Kenichi ;
Sumino, Yasukiyo .
WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (40) :5753-5758
[44]   Utility of contrast-enhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinoma [J].
Masuzaki, Ryota ;
Shiina, Shuichiro ;
Tateishi, Ryosuke ;
Yoshida, Haruhiko ;
Goto, Eriko ;
Sugioka, Yosuke ;
Kondo, Yuji ;
Goto, Tadashi ;
Ikeda, Hitoshi ;
Omata, Masao ;
Koike, Kazuhiko .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (04) :759-764
[45]   Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography:A pilot study [J].
Kazue Shiozawa ;
Manabu Watanabe ;
Yoshinori Kikuchi ;
Takahide Kudo ;
Kenichi Maruyama ;
Yasukiyo Sumino .
World Journal of Gastroenterology, 2012, (40) :5753-5758
[46]   Contrast-Enhanced Ultrasonography: A Recent Application for the Diagnosis and Treatment of Hepatocellular Carcinoma [J].
Maruyama, H. ;
Yoshikawa, M. ;
Yokosuka, O. .
JOURNAL OF NEPAL MEDICAL ASSOCIATION, 2008, 47 (03) :156-166
[47]   Evaluation of therapeutic effectiveness of transarterial chemoembolization for hepatocellular carcinoma: correlation of dynamic susceptibility contrast-enhanced echoplanar imaging and hepatic angiography [J].
Tsui, EYK ;
Chan, JHM ;
Cheung, YK ;
Cheung, CC ;
Tsui, WC ;
Szeto, ML ;
Lau, KW ;
Yuen, MK ;
Lulin, SH .
CLINICAL IMAGING, 2000, 24 (04) :210-216
[48]   Comparison of contrast-enhanced ultrasound and contrast-enhanced computed tomography in evaluating the treatment response to transcatheter arterial chemoembolization of hepatocellular carcinoma using modified RECIST [J].
Ming Liu ;
Man-xia Lin ;
Ming-de Lu ;
Zuo-feng Xu ;
Ke-guo Zheng ;
Wei Wang ;
Ming Kuang ;
Wen-quan Zhuang ;
Xiao-yan Xie .
European Radiology, 2015, 25 :2502-2511
[49]   Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization [J].
Yossi Ventura ;
Brian I Carr ;
Issac Kori ;
Vito Guerra ;
Oren Shibolet .
World Journal of Gastroenterology, 2018, (15) :1641-1649
[50]   Factors Predicting Survival after Transarterial Chemoembolization of Unresectable Hepatocellular Carcinoma [J].
Hanif, Farina M. ;
Tasneem, Abbas Ali ;
Luck, Nasir Hassan ;
Abbas, Zaigham ;
Hassan, Syed Mujahid ;
Mubarak, Muhammed .
MIDDLE EAST JOURNAL OF CANCER, 2014, 5 (04) :197-205